CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis
Previously, we described an APC-adenovirus (APC-Ad) FasL cell gene therapy method which could be used to deplete autoreactive T cells in vivo. FasL was toxic, however, and controlled regulation of FasL was not achieved. Here we describe an improved approach to delivering TNF-related apoptosis-induci...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228459/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14597760/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19209 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
